NYSEMKT: SERSerina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?
Insider buying vs selling
Have Serina Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Juvenescence Ltd | 10% Owner | 2025-01-31 | 500,000 | $10.00 | $5.00MBuy |
| Gregory Bailey | Director | 2024-12-17 | 3,866 | $4.59 | $17.74kBuy |
| Juvenescence Ltd | 10% Owner | 2024-11-27 | 500,000 | $10.00 | $5.00MBuy |
| Gregory Bailey | Director | 2024-09-20 | 1,137 | $6.03 | $6.85kBuy |
| Gregory Bailey | Director | 2024-09-19 | 11,679 | $6.11 | $71.38kBuy |
| Gregory Bailey | Director | 2024-09-18 | 2,709 | $6.23 | $16.87kBuy |
| Steven Mintz | Director | 2024-09-12 | 6,000 | $6.47 | $38.81kBuy |
| Gregory Bailey | Director | 2024-08-20 | 1,776 | $8.25 | $14.65kBuy |
| Gregory Bailey | Director | 2024-08-19 | 6,400 | $7.93 | $50.76kBuy |
| Gregory Bailey | Director | 2024-08-16 | 6,400 | $7.31 | $46.78kBuy |
SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SER insiders and whales buy or sell their stock.
SER Shareholders
What type of owners hold Serina Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Juvenescence Ltd | 225.55% | 22,481,876 | $129.16M | Insider |
| Juvenescence Us Corp | 165.01% | 16,447,500 | $94.49M | Insider |
| Steven A. Ledger | 3.25% | 323,657 | $1.86M | Insider |
| John F. Mauldin | 1.25% | 125,000 | $718.13k | Insider |
| Broadwood Capital Inc | 0.85% | 85,219 | $489.58k | Institution |
| Waverly Advisors LLC | 0.68% | 67,492 | $387.74k | Institution |
| Gregory Bailey | 0.67% | 67,243 | $386.31k | Insider |
| Vanguard Group Inc | 0.62% | 62,073 | $356.61k | Institution |
| Tacey Viegas | 0.59% | 58,610 | $336.71k | Insider |
| Judith Segall | 0.53% | 52,624 | $302.32k | Insider |
SER vs Biotech Stocks
Serina Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.